| Prev Close | 0.56 |
| Open | 0.59 |
| Day Low/High | 0.54 / 0.59 |
| 52 Wk Low/High | 0.23 / 1.07 |
| Volume | 1.64M |
| Avg Volume | 1.37M |
Conatus Pharmaceuticals Inc. (CNAT)
0.56
0.00
0.18
NASDAQ : Health Technology
| Exchange | NASDAQ |
| Shares Outstanding | 33.17M |
| Market Cap | 18.44M |
| EPS | -0.30 |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
Surveying the NASH Drug Landscape
Biotech investors should keep a close eye on the progress in this huge potential market.
The Only Choice: Find Something to Buy
If you can't beat them, then join them.
Market Sees Rise in Performance Anxiety
I've got my eye on steel and biotechnology names to put cash to work.
Traders Are Cleaning Out Their Portfolios
Thin trading is impeding momentum, but here are 4 stocks on my radar.
Rev's Forum: Pension Fund Rebalancing Acts Could Impact 2016's Finish
Will pension funds sell stocks after their run higher in order to maintain the same allocation levels to bonds and equities?
Santa Claus Rally: Ya Gotta Believe
Today's action is a classic example.
These Biotech Names Are on My Radar
But I'm expecting that things will slow into the Fed news.
Why I'm Sticking With Biotech
They offer a nice shelter for the headwinds now hitting equities.
A Biotech With Enormous Potential
The market seems to be severely discounting DynaVax's chances of approval for its hep-B treatment.
Invest in a Healthy Liver
Drugs for liver diseases are good opportunities.
Drifting Into Weekend Mode
The danger is that market players start selling out of boredom.
And We're Off!
Here we go. By Bret Jensen The market is slightly up across the board in the first 30 minutes of trading, and the 10-year Treasury yield is approaching 2.65%. Deckers Outdoor (DECK) is nicely up due to an upgrade at Wells Fargo, which now has price ...